EEF1A1P38: A Potential Drug Target and Biomarker (G124199)

Target Name: EEF1A1P38

NCBI ID: G124199

EEF1A1P38

Other Name(s): Eukaryotic translation elongation factor 1 alpha 1 pseudogene 38 | eukaryotic translation elongation factor 1 alpha 1 pseudogene 38

EEF1A1P38: A Potential Drug Target and Biomarker

The evolution of the protein universe has led to an tremendous increase in the number of gene families, and the discovery of new biomarkers has become an essential part of the drug development process. Eukaryotic Translation Elongation Factor 1 (ETF1) alpha 1 pseudogene 38 (EEF1A1P38 ) is one of the promising candidates as a drug target or biomarker. This gene has been identified as a potential drug target due to its involvement in various cellular processes, including cell signaling, DNA replication, and stress response.

The EEF1A1P38 gene is a member of the ETF1 family, which is known to be involved in the regulation of protein translation in eukaryotic cells. The ETF1A1P38 gene is expressed in various tissues and cells of the body, including the brain, heart, and gastrointestinal tract , and its expression level is regulated by various factors, including DNA methylation and histone modifications.

One of the key functions of the EEF1A1P38 gene is its role in the regulation of protein translation. Protein translation is the process by which cells produce the proteins they need to perform various cellular functions. The EEF1A1P38 gene is involved in the regulation of the translation of specific proteins, which are essential for cell signaling, DNA replication, and stress response.

In addition to its role in protein translation, the EEF1A1P38 gene is also involved in various cellular processes that are crucial for maintaining cellular homeostasis. For instance, the EEF1A1P38 gene is involved in the regulation of cell signaling, which is critical for maintaining the integrity of cellular structures and function. The EEF1A1P38 gene is also involved in the regulation of DNA replication, which is critical for maintaining genetic diversity and cell growth.

The EEF1A1P38 gene has also been shown to be involved in various stress response pathways. During stress, cells are exposed to various stressors, including ions, mutations, and radiation, which can damage cellular structures and disrupt cellular function. the regulation of stress response pathways, which are critical for maintaining cellular homeostasis and resilience to stress.

The potential drug targets for EEF1A1P38 are numerous. For instance, the EEF1A1P38 gene has been shown to be involved in various cellular signaling pathways, including the regulation of cell signaling, cell growth, and stress response. Therefore, potential drug targets for the EEF1A1P38 gene could include compounds that inhibit these signaling pathways, or compounds that modulate the expression of the EEF1A1P38 gene.

Another potential drug target for the EEF1A1P38 gene is its role in the regulation of protein translation. Specific drugs that have been shown to inhibit protein translation, such as rapamycin and broccoli, may be effective in targeting the EEF1A1P38 gene. Additionally, drugs that have been shown to modulate the expression of the EEF1A1P38 gene, such as RNA interference and small interfering RNA, may also be effective in targeting this gene.

The EEF1A1P38 gene is also a potential biomarker for various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. The expression of the EEF1A1P38 gene has been observed in various tissues and diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. Therefore, the EEF1A1P38 gene may be a useful biomarker for the diagnosis and

Protein Name: Eukaryotic Translation Elongation Factor 1 Alpha 1 Pseudogene 38

The "EEF1A1P38 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about EEF1A1P38 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets